Literature DB >> 30422740

Optimizing Cardiovascular Care in Children With Acute Myeloid Leukemia to Improve Cancer-Related Outcomes.

Saro H Armenian1, Matthew J Ehrhardt2.   

Abstract

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 14-year-old African American female presented with fatigue, easy bruising, and fever. On examination, she had scattered bruising, lymphadenopathy, and hepatosplenomegaly. Laboratory evaluation revealed pancytopenia with peripheral blasts, and acute myeloid leukemia (AML; French-American-British M2, t[8;21][q22;q22.1]) was diagnosed on bone marrow biopsy. A baseline echocardiogram revealed normal left ventricular (LV) systolic function (ejection fraction [EF], 60%; shortening fraction [SF], 32%), and conventional chemotherapy was initiated that consisted of two cycles of remission induction (cytarabine, etoposide, and daunorubicin [50 mg/m2 × 3 days per cycle]) followed by intensification 1 (high-dose cytarabine and etoposide), intensification 2 (high-dose cytarabine and mitoxantrone [12 mg/m2/dose daily; four total doses]), and intensification 3 (high-dose cytarabine and l-asparaginase). Of note, an echocardiogram was not repeated before the start of intensification 1. During intensification 1, the patient developed Streptococcus viridans sepsis, which required 4 days in the intensive care unit with antimicrobial and inotropic support. Repeat echocardiogram after recovery from the sepsis episode demonstrated low-normal LV systolic function (EF, 53%; SF, 27%), and she subsequently began intensification 2. On day 3 of intensification 2, the patient developed afebrile tachypnea, tachycardia, and an increasing oxygen requirement. Chest x-ray revealed cardiomegaly and pulmonary vascular congestion. Cardiac troponins were normal, whereas N-terminal pro B-type natriuretic peptide was 10 times the upper limit of normal. Repeat echocardiogram showed an enlarged LV with moderate to severely depressed LV function (EF, 28%; SF, 14%). Day 4 mitoxantrone was omitted and a cardiology consult obtained.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30422740     DOI: 10.1200/JCO.18.01421

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  6 in total

Review 1.  Cardiovascular diseases in survivors of childhood cancer.

Authors:  Neha Bansal; Javier G Blanco; Umesh C Sharma; Saraswati Pokharel; Shannon Shisler; Steven E Lipshultz
Journal:  Cancer Metastasis Rev       Date:  2020-03       Impact factor: 9.264

2.  Multimodality imaging in the assessment of bone marrow-derived mesenchymal stem cell therapy for doxorubicin-induced cardiomyopathy.

Authors:  Chanjuan Qu; Jian Wang; Yuqing Wang; Fangfei He; Xudong Shi; Zhuoli Zhang; Yining Wang
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 3.  Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy.

Authors:  Wei Huang; Rong Xu; Bin Zhou; Chao Lin; Yingkun Guo; Huayan Xu; Xia Guo
Journal:  Front Cardiovasc Med       Date:  2022-06-10

4.  Long-term cardiac-specific mortality among 44,292 acute myeloid leukemia patients treated with chemotherapy: a population-based analysis.

Authors:  Guangli Li; Zhijuan Zhou; Wencong Yang; Hao Yang; Xiuwu Fan; Yuelan Yin; Liyun Luo; Jinyou Zhang; Niujian Wu; Zibin Liang; Jianting Ke; Jian Chen
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

Review 5.  Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors.

Authors:  Neha Bansal; M Jacob Adams; Sarju Ganatra; Steven D Colan; Sanjeev Aggarwal; Rudolf Steiner; Shahnawaz Amdani; Emma R Lipshultz; Steven E Lipshultz
Journal:  Cardiooncology       Date:  2019-12-02

6.  Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.

Authors:  Lindsay L Puckett; Shahryar G Saba; Sonia Henry; Stacey Rosen; Elise Rooney; Samaria L Filosa; Philip Gilbo; Karalyn Pappas; Alison Laxer; Katherine Eacobacci; Amitha N Kapyur; Justin Robeny; Samantha Musial; Anisha Chaudhry; Rahul Chaudhry; Martin L Lesser; Adam Riegel; Sariah Ramoutarpersaud; Navid Rahmani; Amar Shah; Vivian Papas; Toluwani Dawodu; Jessica Charlton; Jonathan P S Knisely; Lucille Lee
Journal:  Cancer Med       Date:  2021-07-10       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.